Metraipolis › archive › dc_902fdba506ee

NR3C1, LAX1, and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer — Europe PMC PMID:41930338

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41930338
DOI
10.1002/mco2.70682
License (as archived)
solo-consultazione
Archived
2026-11-04T02:52:22.656Z
SHA-256 of the archived text
72888038c3ec5a84c28b2f9190957290db2f68977073c5d4a5683fb858066bfb
Stable URL of this page
https://metraipolis.com/documento/dc_902fdba506ee

How to cite

NR3C1, LAX1, and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer — Europe PMC PMID:41930338 — Europe PMC (en), https://europepmc.org/article/MED/41930338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_902fdba506ee (Metraipolis archive dc_902fdba506ee, sha256 72888038c3ec5a84c28b2f9190957290db2f68977073c5d4a5683fb858066bfb)
BibTeX
@misc{dc902fdba506ee,
  title = {NR3C1, LAX1, and RCAN3 as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer — Europe PMC PMID:41930338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41930338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_902fdba506ee; sha256 72888038c3ec5a84c28b2f9190957290db2f68977073c5d4a5683fb858066bfb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41930338. Agents can read the archived copy with the MCP tool read_document.